ReconRegulatory

Medacta Receives CE Marking for the Lateralized Glenosphere

CASTEL SAN PIETRO, 8 October 2019 – Medacta International has recently obtained CE marking for the lateralized glenosphere. This new implant further expands the Medacta offering for shoulder arthroplasty, which now features a broader range of options for reverse shoulder replacement surgery.

The Medacta Shoulder System is a modular solution that includes wide-ranging sizes, adjustable offset and innovative configurations both in the anatomic and reverse configuration. It is compatible with, and can be further enhanced by, the CT-based MyShoulder 3D preoperative planning solution, offering patient-specific humeral and glenoid guides.

The lateralized glenosphere features a more lateralized centre of rotation compared to the standard glenosphere already included in the Medacta Shoulder System offering. The potential benefits are an improved range of motion, as well as a reduced risk of scapular notching.

This new CE mark clearance exemplifies Medacta’s continuous commitment to leverage expertise gained throughout orthopaedics for the development of exceptional shoulder solutions.

For more information on Medacta Shoulder System and Medacta’s shoulder arthroplasty solutions, visit https://www.medacta.com/EN/global-shoulder.

Contact Medacta International SA

Gianluca Olgiati

Senior Director Global Marketing

Phone: +41 91 696 60 60

media@medacta.ch

About Medacta

Medacta is an international company specializing in the design and production of innovative orthopaedic products and the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta’s products and surgical techniques are characterized by innovation. Medacta is a pioneer in developing new offerings on the basis of minimally invasive surgical techniques, in particular its Anterior Minimally Invasive Surgery (“AMIS”) technique for hip replacements. Medacta has leveraged its orthopaedic expertise and comprehensive understanding of the human body to develop the sophisticated “MySolutions” technology, which offers surgeons highly personalized pre-operative planning and implant placement methodologies by creating advanced personalized kinematic models and 3D planning tools for use in hip, knee, shoulder and spine procedures.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button